Biocartis NV has joined forces with the Flanders Institute for Biotechnology (VIB) to develop a new diagnostic test for cancer designed to detect biomarkers of microsatellite instability for several cancers, in particular colorectal cancer. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
